↓ Skip to main content

Dove Medical Press

Article Metrics

Biomarker-based detection of asthma–COPD overlap syndrome in COPD populations

Overview of attention for article published in International Journal of Chronic Obstructive Pulmonary Disease, October 2015
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (53rd percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
4 tweeters

Citations

dimensions_citation
56 Dimensions

Readers on

mendeley
57 Mendeley
Title
Biomarker-based detection of asthma–COPD overlap syndrome in COPD populations
Published in
International Journal of Chronic Obstructive Pulmonary Disease, October 2015
DOI 10.2147/copd.s88274
Pubmed ID
Authors

Tsutomu Tamada, Hisatoshi Sugiura, Tsuneyuki Takahashi, Kazuto Matsunaga, Keiji Kimura, Uichiro Katsumata, Daisuke Takekoshi, Toshiaki Kikuchi, Ken Ohta, Masakazu Ichinose

Abstract

Asthma-chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS) was proposed by the science committees of both Global Initiative for Asthma (GINA) and Global Initiative for Chronic Obstructive Lung Disease (GOLD). However, the definition of ACOS has remained unclear all over the world, and the prevalence rate of ACOS is basically dependent on the patient's symptoms or the physician's opinion, based on questionnaire testing. In the current case report, we investigated the prevalence rate of COPD patients with high levels of fractional exhaled nitric oxide (FENO) or immunoglobulin E (IgE) as candidate markers of ACOS in COPD, as a multicenter, cross-sectional study. Outpatients with COPD were enrolled from Tohoku University Hospital, Sendai, Japan, and five hospitals (Tohoku University Hospital, Sendai, Japan; NTT East Tohoku Hospital, Sendai, Japan; Wakayama Medical University Hospital, Kimiidera, Japan; Hiraka General Hospital, Yokote, Japan; Iwate Prefectural Isawa Hospital, Oshu, Japan) with pulmonary physicians from March 1, 2013 to February 28, 2014. When they were estimated using 35 ppb as the cutoff value of FENO, the prevalence rate of ACOS was 16.3% in COPD. When estimated by both FENO and IgE, the high-FENO/high-IgE group was 7.8% in COPD. To the best of our knowledge, this study is the first to detect the prevalence rate of ACOS in COPD populations by using objective biomarkers. The results from the current study should be useful to identify the subgroup requiring early intervention by inhaled corticosteroids/long-acting beta agonist combination in COPD in order to improve the long-term management for ACOS.

Twitter Demographics

The data shown below were collected from the profiles of 4 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 57 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Portugal 2 4%
Unknown 55 96%

Demographic breakdown

Readers by professional status Count As %
Other 17 30%
Researcher 10 18%
Professor 6 11%
Student > Postgraduate 6 11%
Student > Master 6 11%
Other 11 19%
Unknown 1 2%
Readers by discipline Count As %
Medicine and Dentistry 32 56%
Pharmacology, Toxicology and Pharmaceutical Science 5 9%
Agricultural and Biological Sciences 5 9%
Nursing and Health Professions 1 2%
Mathematics 1 2%
Other 5 9%
Unknown 8 14%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 July 2016.
All research outputs
#3,794,243
of 8,069,135 outputs
Outputs from International Journal of Chronic Obstructive Pulmonary Disease
#490
of 1,013 outputs
Outputs of similar age
#104,676
of 242,627 outputs
Outputs of similar age from International Journal of Chronic Obstructive Pulmonary Disease
#48
of 88 outputs
Altmetric has tracked 8,069,135 research outputs across all sources so far. This one has received more attention than most of these and is in the 50th percentile.
So far Altmetric has tracked 1,013 research outputs from this source. They receive a mean Attention Score of 4.2. This one is in the 47th percentile – i.e., 47% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 242,627 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.
We're also able to compare this research output to 88 others from the same source and published within six weeks on either side of this one. This one is in the 38th percentile – i.e., 38% of its contemporaries scored the same or lower than it.